Both central hypothalamic tumours (usually gangliocytomas) and peripheral neuroendocrine tumours could secrete growth hormone–releasing hormone (GHRH), inducing somatotroph proliferation (and very rarely, the formation of an adenoma), with resultant elevations in levels of growth hormone and IGF-I [18]. This evidence concerns the gene IGF1 and hypothalamic neoplasm.